Search for Clinical Trial Results
Anaplastic Oligoastrocytoma - 58 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma Condition:
|
Active, not recruiting |
Study Name: Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma Condition:
|
Active, not recruiting |
Study Name: Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor Condition:
|
Active, not recruiting |
Study Name: Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor Condition:
|
Completed |
Study Name: Sorafenib in Newly Diagnosed High Grade Glioma Condition:
Interventions: Drug: Sorafenib dose escalation Sorafenib dose escalation scheme: 3 first patients: 200 mg/d, if dose li |
Terminated |
Study Name: Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma Condition:
|
Completed |
Study Name: BIBF 1120 for Recurrent High-Grade Gliomas Condition:
Interventions: Drug: BIBF 1120 200 mg BID oral for 28 day cycle |
Terminated |
Study Name: Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols Condition:
|
Recruiting |
Study Name: WEE1 Inhibitor AZD1775 and Local Radiation Therapy in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas Condition:
|
Recruiting |
Study Name: Phase I/II Trial of Safety and Anti-tumor Efficacy of AXL1717(Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas Condition:
Interventions: Drug: AXL1717 IGF-1 receptor inhibitor Other Name: p |